InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Wasoff Evan L, 首席财务官. Officer active across 1 company, notably Nexien Biopharma, INC.. Aggregated, 9 filings have been logged. Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Wasoff Evan L is Directeur Financier and Chief Financial Officer at Nexien Biopharma, INC. He has 9 filings in total, and the sampled recent filings cover the period from 2021-11-29 to 2024-05-28. The transactions recorded in this recent sample are Attribution, with 0 EUR of purchases and 0 EUR of sales.